Sabelloid Pharmaceutical Private Limited
About Sabelloid Pharmaceutical Private Limited
Data last updated:
Sabelloid Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2015PTC284666. Its GSTIN is 09AAWCS1367D1ZY (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammad Yunus Usman and Muhammad Yusuf.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.J – 1/128 Kh.No.48/2 Second Floor Rear Portion Khirki Extn, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2024, the company reported a revenue of ₹44,900, a decline of 95% compared to the previous year. For the same year it recorded a net loss of ₹44,460 (net margin -99%) and EBITDA of -₹44,460 (EBITDA margin -99%). Revenue has declined at a compounded annual rate (CAGR) of 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sabelloid Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.J – 1/128 Kh.No.48/2 Second Floor Rear Portion Khirki Extn, New Delhi, Delhi, India – 110017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sabelloid Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sabelloid Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sabelloid Pharmaceutical Private Limited, buy the company report.
Financials of Sabelloid Pharmaceutical Private Limited
FY 2024 filings availableSabelloid Pharmaceutical Private Limited reported revenue of ₹44,900 (down 95% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 95% fall in the latest year. EBITDA rose 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹44,460 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹44,460 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -99% | ||||
| Net Profit Margin | -99% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sabelloid Pharmaceutical Private Limited, buy the company report.
Board of directors of Sabelloid Pharmaceutical Private Limited
Sabelloid Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Yunus Usman | Director | 31 Aug 2015 | 11 Years 2 Months | Current |
| Muhammad Yusuf | Director | 07 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Sabelloid Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sigmax Trading Private Limited | ₹45,000 (FY 2025) | 58.0% | New Delhi, Delhi, India | |||
| Bovetas Pharmaceuticals Private Limited | ₹45,000 (FY 2019) | -90.0% | Delhi, India | |||
| Ashtachari Foods Limited | ₹44,998 (FY 2024) | Shirala, Maharashtra, India | ||||
| Valklub Private Limited | ₹44,939 (FY 2021) | Bangalore, Karnataka, India | ||||
| Dexpol Neo Multitrades Private Limited | ₹44,917 (FY 2024) | 3175.0% | Petlawad, Madhya Pradesh, India | |||
| Sabelloid Pharmaceutical Private Limitedthis company | ₹44,900 (FY 2024) | -₹44,460 | -99% | -95.0% | New Delhi, Delhi, India | |
| Visiting Human India Private Limited | ₹44,853 (FY 2021) | Delhi, India | ||||
| Nynbe Multi Business Private Limited | ₹44,815 (FY 2025) | -22.0% | Ahmednagar, Maharashtra, India | |||
| Aarben Biotech Private Limited | ₹44,780 (FY 2017) | -8.0% | Surat, Gujarat, India | |||
| Ekilogram Expo Private Limited | ₹44,768 (FY 2025) | Vadodara, Gujarat, India | ||||
| Addven Solutions Private Limited | ₹44,717 (FY 2023) | -13.0% | Thane, Maharashtra, India |
To see the full peer comparison of Sabelloid Pharmaceutical Private Limited, buy the company report.
Auditor
Sabelloid Pharmaceutical Private Limited is audited by N KANTAN AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N KANTAN AND ASSOCIATES | FY 2017 | 014757C |
Shareholding
The shareholding of Sabelloid Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sabelloid Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sabelloid Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sabelloid Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sabelloid Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAWCS1367D1ZY | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sabelloid Pharmaceutical Private Limited, buy the company report.
Recent activity
Sabelloid Pharmaceutical Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Ahmad Umair Usmani ceased to be Director on 08 Jan 2026.
Frequently asked questions
Sabelloid Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 August 2015 (11+ years old) and is registered under CIN U24233DL2015PTC284666.
Sabelloid Pharmaceutical has 2 current directors:
- Mohammad Yunus Usman - Director
- Muhammad Yusuf - Director
The latest financial statements of Sabelloid Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sabelloid Pharmaceutical is 09AAWCS1367D1ZY, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sabelloid Pharmaceutical is U24233DL2015PTC284666. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sabelloid Pharmaceutical was incorporated on 31 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sabelloid Pharmaceutical by revenue are Sigmax Trading Private Limited, Bovetas Pharmaceuticals Private Limited, Ashtachari Foods Limited, Valklub Private Limited, Dexpol Neo Multitrades Private Limited and 5 more, all in the same principal business activity (retail trading).
Ahmad Umair Usmani ceased to be Director on 08 Jan 2026. Muhammad Yusuf was appointed as Director on 07 Jan 2026. Ahmad Umair Usmani was appointed as Director on 31 Aug 2015. Sabelloid Pharmaceutical has 4 board changes on record in total.
The registered office of Sabelloid Pharmaceutical is at H.No.J – 1128 Kh.No.482 Second Floor Rear Portion Khirki Extn, New Delhi, Delhi, India – 110017.
Sabelloid Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sabelloid Pharmaceutical is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
